Stock & Company Details
Gyre Therapeutics Inc $GYRE
Price:
N/A
N/A
112M
$761M
52 Week High:
N/A
10 Day Average Volume:
N/A
-95.61
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GYRE technical indicators
Latest Gyre Therapeutics Inc (GYRE) indicator readings as of 2026-09-18.
GYRE's 14-day RSI is 68.0, in neutral territory. At $7.55 it is trading 6.2% above its 200-day moving average of $7.11, and above its 50-day average of $6.50. Price sits above the upper Bollinger Band ($6.19 to $7.32). ADX reads 18.4, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Finance Bot
Ask your questions
Start by typing a question below.
